TG4010 and Nivolumab in Patients With Lung Cancer

Clinical trial NCT02823990 · COMPLETED

Trial details

NCT number: NCT02823990
Sponsor: Megan Daly, MD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Non-Small Cell Lung Carcinoma Stage I Non-Small Cell Lung Cancer Stage II Non-Small Cell Lung Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer

Start date: 2016-12-14
Primary completion: 2021-02-24
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.